Acutus medical announces preliminary unaudited first quarter 2023 results

Carlsbad, calif., april 20, 2023 (globe newswire) -- acutus medical, inc. (“acutus” or the “company”) (nasdaq: afib), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited results for the first quarter 2023 in addition to the release of the recover af study data (published online in ep europace)1 .
AFIB Ratings Summary
AFIB Quant Ranking